Krystyna Kowalczyk Named CEO of Moffitt Cancer Center’s Immunotherapy Contract Research Organization
TAMPA, Fla. — Krystyna Kowalczyk has joined Moffitt Cancer Center as the chief executive officer of the institution’s new contract research organization (CRO) with a focus on immunotherapy. The wholly owned, for profit subsidiary, first announced in October 2019, will offer end-to-end services for pharmaceutical and biotech companies looking to advance their immuno-oncology product or device.
